These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 14759738)

  • 1. Design of tetrapeptide ligands as inhibitors of the Src SH2 domain.
    Nam NH; Pitts RL; Sun G; Sardari S; Tiemo A; Xie M; Yan B; Parang K
    Bioorg Med Chem; 2004 Feb; 12(4):779-87. PubMed ID: 14759738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformationally constrained peptide analogues of pTyr-Glu-Glu-Ile as inhibitors of the Src SH2 domain binding.
    Nam NH; Ye G; Sun G; Parang K
    J Med Chem; 2004 Jun; 47(12):3131-41. PubMed ID: 15163193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydrophobic D-amino acids in the design of peptide ligands for the pp60src SH2 domain.
    Plummer MS; Lunney EA; Para KS; Prasad JV; Shahripour A; Singh J; Stankovic CJ; Humblet C; Fergus JH; Marks JS; Sawyer TK
    Drug Des Discov; 1996 Apr; 13(3-4):75-81. PubMed ID: 8874045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphotyrosine-containing dipeptides as high-affinity ligands for the p56lck SH2 domain.
    Llinaś-Brunet M; Beaulieu PL; Cameron DR; Ferland JM; Gauthier J; Ghiro E; Gillard J; Gorys V; Poirier M; Rancourt J; Wernic D; Betageri R; Cardozo M; Jakes S; Lukas S; Patel U; Proudfoot J; Moss N
    J Med Chem; 1999 Feb; 42(4):722-9. PubMed ID: 10052978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissection of the energetic coupling across the Src SH2 domain-tyrosyl phosphopeptide interface.
    Lubman OY; Waksman G
    J Mol Biol; 2002 Feb; 316(2):291-304. PubMed ID: 11851339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide ligands of pp60(c-src) SH2 domains: a thermodynamic and structural study.
    Charifson PS; Shewchuk LM; Rocque W; Hummel CW; Jordan SR; Mohr C; Pacofsky GJ; Peel MR; Rodriguez M; Sternbach DD; Consler TG
    Biochemistry; 1997 May; 36(21):6283-93. PubMed ID: 9174343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of novel imidazole-substituted dipeptide amides as potent and selective inhibitors of Candida albicans myristoylCoA:protein N-myristoyltransferase and identification of related tripeptide inhibitors with mechanism-based antifungal activity.
    Devadas B; Freeman SK; Zupec ME; Lu HF; Nagarajan SR; Kishore NS; Lodge JK; Kuneman DW; McWherter CA; Vinjamoori DV; Getman DP; Gordon JI; Sikorski JA
    J Med Chem; 1997 Aug; 40(16):2609-25. PubMed ID: 9258368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based design of novel nonpeptide inhibitors of the Src SH2 domain:phosphotyrosine mimetics exploiting multifunctional group replacement chemistry.
    Sundaramoorthi R; Kawahata N; Yang MG; Shakespeare WC; Metcalf CA; Wang Y; Merry T; Eyermann CJ; Bohacek RS; Narula S; Dalgarno DC; Sawyer TK
    Biopolymers; 2003; 71(6):717-29. PubMed ID: 14991680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of dissociation constants of inhibitors binding to Src SH2 domain protein by non-covalent electrospray ionization mass spectrometry.
    Bligh SW; Haley T; Lowe PN
    J Mol Recognit; 2003; 16(3):139-48. PubMed ID: 12833569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A fluorescence polarization based Src-SH2 binding assay.
    Lynch BA; Loiacono KA; Tiong CL; Adams SE; MacNeil IA
    Anal Biochem; 1997 Apr; 247(1):77-82. PubMed ID: 9126374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and synthesis of 4-(alpha-hydroxymalonyl)phenylalanine as a new phosphotyrosyl mimetic and its use in growth factor receptor bound 2 src-homology 2 (Grb2 SH2) domain-binding peptides.
    Kang SU; Worthy KM; Bindu LK; Zhang M; Yang D; Fisher RJ; Burke TR
    J Med Chem; 2005 Aug; 48(16):5369-72. PubMed ID: 16078854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrocyclization in the design of Grb2 SH2 domain-binding ligands exhibiting high potency in whole-cell systems.
    Wei CQ; Gao Y; Lee K; Guo R; Li B; Zhang M; Yang D; Burke TR
    J Med Chem; 2003 Jan; 46(2):244-54. PubMed ID: 12519063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-based design and synthesis of high affinity tripeptide ligands of the Grb2-SH2 domain.
    Furet P; Gay B; Caravatti G; García-Echeverría C; Rahuel J; Schoepfer J; Fretz H
    J Med Chem; 1998 Aug; 41(18):3442-9. PubMed ID: 9719597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solid-phase binding assays of peptides using EGFP-Src SH2 domain fusion protein and biotinylated Src SH2 domain.
    Ye G; Ayrapetov M; Nam NH; Sun G; Parang K
    Bioorg Med Chem Lett; 2005 Nov; 15(22):4994-7. PubMed ID: 16169725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and cocrystal structure of a nonpeptide Src SH2 domain ligand.
    Plummer MS; Holland DR; Shahripour A; Lunney EA; Fergus JH; Marks JS; McConnell P; Mueller WT; Sawyer TK
    J Med Chem; 1997 Nov; 40(23):3719-25. PubMed ID: 9371236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutational investigation of the specificity determining region of the Src SH2 domain.
    Bradshaw JM; Mitaxov V; Waksman G
    J Mol Biol; 2000 Jun; 299(2):521-35. PubMed ID: 10860756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitors to the Src SH2 domain: a lesson in structure--thermodynamic correlation in drug design.
    Henriques DA; Ladbury JE
    Arch Biochem Biophys; 2001 Jun; 390(2):158-68. PubMed ID: 11396918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent inhibition of Grb2 SH2 domain binding by non-phosphate-containing ligands.
    Yao ZJ; King CR; Cao T; Kelley J; Milne GW; Voigt JH; Burke TR
    J Med Chem; 1999 Jan; 42(1):25-35. PubMed ID: 9888830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structures of the human p56lck SH2 domain in complex with two short phosphotyrosyl peptides at 1.0 A and 1.8 A resolution.
    Tong L; Warren TC; King J; Betageri R; Rose J; Jakes S
    J Mol Biol; 1996 Mar; 256(3):601-10. PubMed ID: 8604142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of phosphotyrosine recognition by the SH2 domain of the Src kinase.
    Bradshaw JM; Mitaxov V; Waksman G
    J Mol Biol; 1999 Nov; 293(4):971-85. PubMed ID: 10543978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.